GPCR modulators (Sosei Heptares /Astrazeneca)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGPCR modulators (Sosei Heptares /Astrazeneca)
Drug Alias NameGPCR modulators (Heptares/Astrazeneca)AZ-3451AZ-8838
ClassificationSmall molecules
Mechanisms of ActionProtease-activated receptor-2 antagonistsCNS modulators
TargetsProtease-activated receptor-2
Therapy Area/IndicationsPainInflammationMetabolic Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma UK Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNxera Pharma UK LtdAstrazeneca PlcNxera Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsPainInflammationMetabolic Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A